The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Biocartis; Chrysalis Biomedical Advisors; COMM Santé; Lilly; Pierre Fabre; Sanofi; SERVIER; SERVIER
Adapted physical activity in patients (Pts) with advanced pancreatic cancer (APACaP): Results from a prospective national randomized GERCOR trial.
 
Cindy Neuzillet
No Relationships to Disclose
 
Olivier Bouché
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; Pierre Fabre; Sanofi; Servier
 
Christophe Tournigand
Honoraria - Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
Consulting or Advisory Role - Bayer
Research Funding - Roche
Travel, Accommodations, Expenses - Bayer; MSD; Roche
 
Benoist Chibaudel
No Relationships to Disclose
 
Lucile Bouguion
No Relationships to Disclose
 
Leila Bengrine-Lefevre
No Relationships to Disclose
 
Daniel Lopez-Trabada Ataz
No Relationships to Disclose
 
May Mabro
No Relationships to Disclose
 
Jean-Philippe Metges
Honoraria - BMS; Lilly; Novartis; Sanofi; SynCoreBio
Travel, Accommodations, Expenses - Amgen; Amgen; LEO Pharma; MSD Oncology; MSD Oncology; MSD Oncology
 
Denis Péré-Vergé
No Relationships to Disclose
 
Thierry Conroy
No Relationships to Disclose
 
Astrid Lievre
Honoraria - Advanced Accelerator Applications; Amgen; Bayer; Bristol-Myers Squibb (Mexico); Incyte; Ipsen; LEO Pharma; Mylan; Novartis; Pierre Fabre; Roche; SERVIER; Viatris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bristol-Myers Squibb (Mexico); Incyte; Pierre Fabre; SERVIER
Research Funding - Bayer (Inst); IntegraGen (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Ipsen; MSD Oncology; Mylan; Pierre Fabre; Roche; SERVIER
 
Morgan Andre
No Relationships to Disclose
 
Françoise Desseigne
No Relationships to Disclose
 
François Goldwasser
Consulting or Advisory Role - Baxter; Fresenius Kabi; NUTRICIA
Research Funding - Baxter (Inst)
 
Julie Henriques
No Relationships to Disclose
 
Amélie Anota
Consulting or Advisory Role - Amgen; AstraZeneca; Ipsen
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Pascal Hammel
Consulting or Advisory Role - AstraZeneca (Inst); ERYTECH Pharma (Inst); IPSEN (Inst); Mylan; Rafael Pharmaceuticals; VECT-HORUS
Speakers' Bureau - AstraZeneca; Mylan; SERVIER
Research Funding - AstraZeneca (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Halozyme; Ipsen; Pfizer/EMD Serono; Shire; Vect-Horus